ABSTRACT:
Purpose: In recent years, because of the globalization and industrialization there is Unhygienic conditions in the undeveloped countries. Pollution in developing and developed countries resulted in the a pathetic raise in the number of life-threatening infections. Because os these various reasons, there is an increase in various species of fungal infections. Poor bioavailability of ophthalmic solutions caused by dilution and drainage from the eye can be overcome by using a self-emulsifying drug delivery system. This may result in better ocular availability of the drug. Though it is a potent antifungal, according to BCS, Ketoconazole is categorized under class-2, which is having high permeability and low solubility. Thus, it suffers from a problem in formulation development with poor bioavailability and low aqueous solubility. Objective: The objective of the present study was to Formulation and Evaluation of the emulsifying drug delivery system of Ketoconazole. Methodology: The Preformulation study was carried out to identify and characterize the procured drug sample by UV spectroscopy, FTIR, and DSC. A preliminary solubility study was performed. oleic acid, Cremophore RH 40, and Propylene glycol have been utilized for the development of SMEDDS of Ketoconazole. A pseudo ternary phase diagram was constructed. 32 Factorial Design has been used for the optimization of SMEDDS. Formulated SMEDDS was evaluated for the parameters of Dilution study by visual observation, Self-emulsification time, Percentage transmission, zeta potential, particle size, and PDI. The in-vitro drug release study was carried out. The stability study of optimized formulation was carried out.
Cite this article:
Shital P Khavare, Pooja P. Rayanade, Shrivardhan M. Bolaj. Formulation and Evaluation of Ophthalmic Self Emulsifying Drug Delivery System of Ketoconazole. Research Journal of Pharmaceutical Dosage Forms and Technology.2025; 17(3):172-8. doi: 10.52711/0975-4377.2025.00024
Cite(Electronic):
Shital P Khavare, Pooja P. Rayanade, Shrivardhan M. Bolaj. Formulation and Evaluation of Ophthalmic Self Emulsifying Drug Delivery System of Ketoconazole. Research Journal of Pharmaceutical Dosage Forms and Technology.2025; 17(3):172-8. doi: 10.52711/0975-4377.2025.00024 Available on: https://rjpdft.com/AbstractView.aspx?PID=2025-17-3-2
REFERENCES:
1. ElKasabgy NA. Ocular supersaturated self-nanoemulsifying drug delivery systems (S-SNEDDS) to enhance econazole nitrate bioavailability. International Journal of Pharmaceutics. 2014; 460(1-2): 33-44.
2. Tiwari R, Dubey V, Kesavan K. Ocular self-microemulsifying drug delivery system of prednisolone improves therapeutic effectiveness in the treatment of experimental uveitis. Ocular Immunology and Inflammation. 2019; 27(2): 303-11.
3. Duxfield L, Sultana R, Wang R, et al. Ocular delivery systems for topical application of anti-infective agents. Drug Development & Industrial Pharmacy. 2015; 42(1): 1-11.
4. Kakkar S, Karuppayil SM, Raut JS, Giansanti F, Papucci L, Schiavone N, Kaur IP. Lipid-polyethylene glycol-based nano-ocular formulation of ketoconazole. International Journal of Pharmaceutics. 2015; 495(1): 276-89.
5. Oh DH, Kang JH, Kim DW, Lee BJ, Kim JO, Yong CS, Choi HG. Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier. International Journal of Pharmaceutics. 2011; 420(2): 412-8.
6. Stegemann S, Leveiller F, Franchi D, De Jong H, Lindén H. When poor solubility becomes an issue: from early stage to proof of concept. European Journal of Pharmaceutical Sciences. 2007; 31(5): 249-61.
7. Tavakoli M, Mahboobian MM, Nouri F, Mohammadi M. Studying the ophthalmic toxicity potential of developed ketoconazole loaded nanoemulsion in situ gel formulation for ophthalmic administration. Toxicology Mechanisms and Methods. 2021; 31(8): 572-80.
8. Shrestha H, Bala R, Arora S. Lipid-based drug delivery systems. Journal of Pharmaceutics. 2014; 77.
9. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomedicine and Pharmacotherapy. 2004; 58(3): 173-82.
10. Kumar R, Sinha VR. Preparation and optimization of voriconazole microemulsion for ocular delivery. Colloids and Surfaces B: Biointerfaces. 2016; 117: 82-8.
11. Basalious EB, Shawky N, Badr-Eldin SM. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. International Journal of Pharmaceutics. 2010; 391(1-2): 203-11
12. Akula S, Gurram AK, Devireddy SR. Self-microemulsifying drug delivery systems: an attractive strategy for enhanced therapeutic profile. International Scholarly Research Notices. 2014; 74
13. Zhang P, Liu Y, Feng N, Xu J. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. International Journal of Pharmaceutics. 2008; 355(1-2): 269-76.
14. Yousry C, Zikry PM, Basalious EB, El-Gazayerly ON. Self-nanoemulsifying System Optimization for Higher Terconazole Solubilization and Non-Irritant Ocular Administration. Adv Pharm Bull. 2020; 10(3): 389-398. doi: 10.34172/apb.2020.047.
15. Kawakami K, Yoshikawa T, Moroto Y, Kanaoka E, Takahashi K, Nishihara Y, Masuda K. Microemulsion formulation for enhanced absorption of poorly soluble drugs: I. Prescription design. Journal of Controlled Release. 2002; 81(1-2): 65-74.
16. Abdelbary GA, Amin MM, Zakaria MY. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies. Drug Delivery. 2017; 24(1): 309-19.
17. Zhang P, Liu Y, Feng N, Xu J. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. International Journal of Pharmaceutics. 2008; 355(1-2): 269-76